Medical Decision Making

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Register here to gain access to SAGE's 500+ Journals Online

Click here to browse AJSM online!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schwartz, L. M.
Right arrow Articles by Welch, H. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwartz, L. M.
Right arrow Articles by Welch, H. G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
This version was published on October 1, 2007
Medical Decision Making, Vol. 27, No. 5, 655-662 (2007)
DOI: 10.1177/0272989X07306786

The Drug Facts Box: Providing Consumers with Simple Tabular Data on Drug Benefit and Harm

Lisa M. Schwartz, MD, MS

VA Outcomes Group (111B), Department of Veterans Affairs Medical Center, White River Junction

Steven Woloshin, MD, MS

VA Outcomes Group (111B), Department of Veterans Affairs Medical Center, White River Junction, steven.woloshin{at}dartmouth.edu

H. Gilbert Welch, MD, MPH

VA Outcomes Group (111B), Department of Veterans Affairs Medical Center, White River Junction

Context. Direct-to-consumer drug ads have been criticized for providing inadequate and misleading information. Requiring ads to include a table with data on drug benefits and side effects (derived from clinical trials) could help, provided that consumers understand such tabular information. Objective. To determine if people could understand and use a 9-row x 2-column ``study findings table'' presenting expected outcomes (both beneficial and harmful) with and without a drug. Subjects.A convenience sample of 274 participants: 186 recruited from alumni of Dartmouth's ``Community Medical School'' public lecture series and Dartmouth Hitchcock's Center for Shared Decision Making and 88 veterans and their families recruited from waiting rooms in the Veterans Affairs outpatient clinic, White River Junction, Vermont. Design. Cross-sectional survey. Participants were tested on their comprehension of the study findings table about the drug tamoxifen used for the primary prevention of breast cancer—with no instructions on how to use the table. Main outcome measure. Five comprehension questions testing how well participants could read and use the table with drug benefits and side effects data. Results. On average, participants correctly answered 4 of the 5 table comprehension questions: 89% correctly used the table to determine the percentage of womengiventamoxifenwhogotabloodclotintheirlegsor lungs, and 71% were able to use data in the table to calculate the absolute difference in the proportion of women who got breast cancer in the tamoxifen v. the placebo group. Most participants were also able to use the table to make comparisons. Conclusion. Most participants—even those with lower formal educational attainment—were able to understand and use the tabular data.

Key Words: Key words: risk communication • decision aids • pharmaceutical decision making. (Med Decis Making 2007;27:655—662)

References

  • Bell R., Wilkes M., Kravitz R. The educational value of consumer-target prescription drug print advertising. J Fam Pract. 2000;49:1092—8.[ISI][Medline] [Order article via Infotrieve]
  • Woloshin S., Schwartz L., Tremmel J., Welch H. Direct to consumer drug advertisements: what are Americans being sold? Lancet. 2001;358:1141—6.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Waxman H. Ensuring that consumers receive appropriate information from drug ads: what is the FDA's role? Health Aff (Millwood). 2004 Jan—Jun;Suppl Web Exclusives:W4256—8.
  • Gazmararian JA, Baker DW, Williams MW, et al. Health literacy among Medicare enrollees in a managed care organization. JAMA. 1999;281:545—51.[Abstract/Free Full Text]
  • Kirsch IS, Jungeblut A., Jenkins L., Kolstad A. Adult Literacy in America. Washington, DC: National Center for Education Statistics; 1993.
  • Schwartz LM, Woloshin S., Black WC, Welch HG The role of numeracy in understanding the benefit of screening mammography. Ann Intern Med. 1997;127:966—72.[Abstract/Free Full Text]
  • Woloshin S., Schwartz L., Welch H. The value of benefit data in direct-to-consumer drug ads. Health Aff (Millwood). 2004 Jan— Jun;Suppl Web Exclusives:W234—45.
  • ZENECA Pharmaceuticals. Professional information brochure: Nolvadex (tamoxifen citrate); 1998. Available from: http:// www.fda.gov/cder/foi/label/1998/17970.pdf
  • Fisher B., Costantino J., Wickerman D., et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998;90: 1371—88.[Abstract/Free Full Text]
  • Dartmouth Community Medical School. Available from: http://dms.dartmouth.edu/dcms.
  • Gigerenzer G., Edwards A. Simple tools for understanding risks: from innumeracy to insight. BMJ. 2003;327:741—4.[Free Full Text]
  • Schwartz L., Woloshin S., Welch H. Know Your Chances: Understanding Health Statistics. White River Junction, VT: VA Outcomes Group; 2005.
  • Lipkus I., Samsa G., Rimer B. General performance on a numeracy scale among highly educated samples. Med Decis Making. 2001;21:37—44.[Abstract]
  • Woloshin S., Schwartz LM, Welch HG The effectiveness of a primer to help people understand risk: Two randomized trials in distinct populations. Annals Intern Med. 2007;146:256—65.[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Med Decis MakingHome page
R. M. Hamm, D. E. Bard, E. Hsieh, and H. F. Stein
Contingent or Universal Approaches to Patient Deficiencies in Health Numeracy
Med Decis Making, October 1, 2007; 27(5): 635 - 637.
[PDF]

Home page
 Med Decis MakingHome page
I. M. Lipkus
Numeric, Verbal, and Visual Formats of Conveying Health Risks: Suggested Best Practices and Future Recommendations
Med Decis Making, October 1, 2007; 27(5): 696 - 713.
[Abstract] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schwartz, L. M.
Right arrow Articles by Welch, H. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwartz, L. M.
Right arrow Articles by Welch, H. G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?